Neuralstem Inc. named Kenneth Carter executive chairman, effective Jan. 1, 2019.

Carter will replace Jim Scully, who is stepping down as interim CEO.

Carter is chairman of Noble Life Sciences Inc., a pre-clinical contract research organization for biotechnology and pharmaceutical companies.

Neuralstem focuses on researching and developing nervous system therapies.